• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Non-White race associated with greater SARS-CoV-2 infection and hospitalization risk

byThomas SuandHarsh Shah
February 16, 2021
in Infectious Disease, Public Health
Reading Time: 2 mins read
Initial data on the viability of SARS-CoV-2 in aerosol and on surfaces
Share on FacebookShare on Twitter

1. Black, Hispanic, and Asian patients had significantly higher infection rates for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared to White patients.

2. Asian and Hispanic patients had greater severity of illness at admission compared to White patients.

Evidence Rating Level: 2 (Good)

Study Rundown: Coronavirus disease 2019 (COVID-19) has been reported to disproportionately affect disadvantaged, Hispanic, and Black communities in the United States. While it is largely thought that the disparity is attributed to persons living in more crowded conditions and have a higher number of comorbidities, no comprehensive quantitative analyses between ethnicity and infection rates have been conducted. This study found that race was the strongest predictor of infection with SARS-CoV-2. Furthermore, hospitalization was more frequent among Hispanic, Black, and Asian persons despite White patients being older and having a greater comorbidity burden. This study was limited by potential sampling biases associated with the rapid changes in infection control, testing, and treatment guidelines that defined the beginning of the pandemic. Nonetheless, these findings reinforce the necessity of culturally appropriate community interventions to reduce the spread of SARS-CoV-2.

Click here to read the study in Annals of Internal Medicine

Relevant Reading: Racial and Ethnic Health Disparities Related to COVID-19

RELATED REPORTS

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

Trends in firearm-related hospitalizations and deaths in New Zealand

Worsening kidney function observed following SARS-CoV-2 infection in children

In-Depth [retrospective cohort]: This study included 3,481,716 patients who were members of the Kaiser Foundation Health Plan on 1 February 2020, and either remained enrolled until 31 May 2020 or died in the same period. Collected information included self-reported race/ethnicity, several comorbidities, and severity of illness scores. White patients had the lowest incidence of infection of any group (55.1 per 100,000 persons) whereas Asian, Black, and Hispanic patients all had significantly greater incidences (111.7, 123.1, and 219.6 per 100,000, respectively). These differences were undiminished in multivariate analyses, with race accounting for 80.3% of model explanatory power with regard to infection. The highest adjusted odds ratios (aORs) for infection rates were found among Hispanic patients (aOR, 3.93; 95% confidence interval [CI], 3.59 to 4.30) and Asian patients (aOR, 2.19; 95% CI, 1.98 to 2.42). The severity of illness on admission was highest in Asian persons (12.6 points) followed by Hispanic patients (6.7 points) compared to White patients. Overall, race was shown to be the most important predictor for SARS-CoV-2 infection.

Image: PD 

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: infection ratesracial disparitiesSARS-CoV-2
Previous Post

Enfortumab vedotin prolongs survival in previously treated advanced urothelial carcinoma

Next Post

#VisualAbstract: Nivolumab plus ipilimumab increases overall survival in patients with malignant pleural mesothelioma

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Infectious Disease

Ensitrelvir associated with reduced risk of Covid-19 among household contacts

May 26, 2026
Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis
Public Health

Trends in firearm-related hospitalizations and deaths in New Zealand

September 22, 2025
Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Hematology

Increased blood–urea–nitrogen-to-albumin ratio associated with increased mortality in coronavirus disease

February 10, 2025
Next Post
#VisualAbstract: Nivolumab plus ipilimumab increases overall survival in patients with malignant pleural mesothelioma

#VisualAbstract: Nivolumab plus ipilimumab increases overall survival in patients with malignant pleural mesothelioma

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Posaconazole is non-inferior to voriconazole for primary treatment of invasive aspergillosis

#VisualAbstract: Nivolumab plus ipilimumab increases overall survival in patients with malignant pleural mesothelioma

#VisualAbstract: Positive Anti-Spike or Anti-Nucleocapsid Antibody Status is Associated with Reduced Incidence of SARS-CoV-2 Reinfection in Health Care Workers

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep-learning model achieved high diagnostic performance for detecting cardiac enlargement using electrocardiograms
  • Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors
  • Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.